Elsevier

Respiratory Medicine

Volume 106, Issue 9, September 2012, Pages 1236-1243
Respiratory Medicine

Clinical characteristics of women with menstrual-linked asthma

https://doi.org/10.1016/j.rmed.2012.05.003Get rights and content
Under an Elsevier user license
open archive

Summary

Background

Menstrual-linked asthma (MLA) is described in pre-menopausal women who experience a deterioration of asthma control peri-menstrually. The clinical characteristics of MLA remain incompletely defined. Our objective was to define the characteristics of MLA in a large female asthma cohort.

Methods

Cross-sectional population survey. A comprehensive health questionnaire that included questions about MLA was administered to 1260 consecutive female asthma patients aged 12–55 years. Univariate and multivariate analyses were completed.

Results

The survey response rate was 43% (540/1260). The prevalence of self-reported MLA was 11% (60/540). Univariate: women with MLA compared to women without MLA had more urgent/emergent asthma-related healthcare visits/year, 6.18 (SD = ±6.67) vs. 4.71 (SD = ±5.91) (p = 0.033), more emergency room visits, 1.50 (SD = ±3.57) vs. 0.88 (SD = ±2.27) (p = 0.035), higher asthma-related absenteeism, 33/60 (57%) vs. 170/471 (37%) (p = 0.003), and used almost twice the number of B2-agonist rescue doses/day, 1.13 (SD = ±1.70) vs. 0.68 (SD = ±1.32) (p = 0.015). Multivariate: statistical significance was retained for absenteeism (p = 0.016) and B2-agonist use (p = 0.007) but lost for urgent healthcare visits (p = 0.150) and emergency room visits (p = 0.068).

Conclusions

Self-reported MLA is common. Women with MLA in our population had a greater frequency of urgent healthcare visits, a higher rate of absenteeism, and used significantly more B2-agonist rescue than women without MLA. The association of increased health services use was not confirmed on multivariate analysis indicating that baseline characteristics associated with MLA in our population affected this outcome. MLA should be considered by healthcare providers when developing an asthma management plan.

Keywords

Allergy
Asthma
Human
Menstrual cycle
Respiratory

Abbreviation

FEV1
forced expiratory volume in 1 s
FVC
forced vital capacity
ICS
inhaled corticosteroid
LTRA
leukotriene receptor antagonist
LABA
long acting B2-agonist
MLA
menstrual-linked asthma
PEF
peak-expiratory flow
SD
standard deviation

Cited by (0)